Partenaires

Centre National de la recherche scientifique
Logo de l'université de Toulouse Logo de l'Universite Paul Sabatier
Fédération de recherche en biologie de Toulouse



Search

On this website

On the whole CNRS Web


The research at IPBS

The primary objective of the Institute of Pharmacology and Structural Biology, headed by Jean Philippe GIRARD, is the identification and characterization of novel pharmacological targets in the fields of Cancer and Infectious Diseases (Tuberculosis).

The technology portfolio

News All news

16 May 2013

Novel immune defense mechanisms against visceral leishmaniasis

Novel defense mechanisms against Leishmania infection involving (...) Read more

10 May 2013

A new player in migration of immature dendritic cells

When they recognize a pathogen, dendritic cells initiate a maturation (...) Read more

22 February 2013

Jean-Philippe GIRARD, Silver Medal of the CNRS

The CNRS Silver Medal honors researchers who are only at the beginning (...) Read more

21 December 2012

A new drug target for tuberculosis therapy

One third of the world is infected with the bacterium that causes (...) Read more


Seminars

To be noted

Press Releases

16 May 2013

Resistance to visceral leishmaniasis : new mechanisms involved

Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD (...)

Read more

10 May 2013

A new player in migration of immature dendritic cells

When they recognize a pathogen, dendritic cells initiate a maturation (...)

Read more

1 April 2013

Bacterial protein-O-mannosylating enzyme is crucial for virulence of Mycobacterium tuberculosis

A posttranslational protein O-mannosylation process resembling that (...)

Read more

21 December 2012

A new drug target for tuberculosis therapy

One third of the world is infected with the bacterium that causes (...)

Read more

17 January 2012

A novel mechanism in the activation of IL-33 during inflammation

Inflammation is a mechanism to help the body cope with an injury, (...)

Read more